FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
This article was originally published in The Tan Sheet
Executive Summary
Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products
You may also be interested in...
Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy
A Pharmavite executive outlined a “different perspective” from the conventional wisdom promoted by FDA on successful compliance with dietary supplement good manufacturing practices: an emphasis on finished product specifications.
FDA Measures Supplement Firms' GMP Recordkeeping Burden
FDA will gauge how firms handle one of the most important and difficult aspects of compliance with dietary supplement good manufacturing practices - recordkeeping
As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle
FDA's final rule for dietary supplement good manufacturing practices completed its phase-in for the industry June 25, and the agency now prepares to conduct inspections of small firms, which have struggled the most to comply with the regulation